Skip to main content
. 2022 Sep 16;26(4):295–318. doi: 10.4103/2230-8210.356236

Table 10.

Weight loss targets based on comorbidities[45]

Disease Weight loss in % Expected outcome
Type 2 diabetes mellitus 5-15 Reduction in HbA1c, reduction in drugs, reversal of diabetes
Metabolic syndrome 7-10 Prevention of diabetes
NAFLD 7-10 Reduction in intrahepatocyte fat and NASH resolution (64%-90%)[46]
PCOS 5-15 Ovulation, reduction in insulin resistance and hirsutism
Dyslipidemia 5-15 Reduction in triglyceride and LDL, rise in HDL
Hypertension 5-15 Lower blood pressure and decreased medications
Sleep apnea 7-11 Decrease in apnea and hypopnea index